Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Novel Agent Shows Promise for T1351 Positive Chronic Myeloid Leukemia
Link ID 20768
Title Novel Agent Shows Promise for T1351 Positive Chronic Myeloid Leukemia
Url http://www.medscape.com/viewarticle/713468?src=rss
Description The investigational agent omacetaxine might be a viable treatment option for patients with T3151 positive chronic myeloid leukemia who do not respond to tyrosine kinase inhibitors. Medscape Medical News
Category Articles > Family Medicine
Keywords
Date Dec 8, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Family Medicine
1. The Experience of Being Obese and Pregnant
  Obese women report startlingly negative attitudes from providers of prenatal and maternity healthcare. Medscape Nurses
Category:   Articles > Family Medicine


2. Guidelines Address HIV Testing, Prophylaxis to Prevent Mother-to-Child Transmission
  An American Academy of Pediatrics policy statement summarizes the guidelines for HIV testing and prophylaxis to prevent mother-to-child transmission of HIV in the United States. Medscape Medical News
Category:   Articles > Family Medicine


3. SMFM 2009: Gestational Weight Loss May Improve Outcomes Among Obese Women
  Minimal weight gain or even weight loss among obese women during pregnancy is not associated with negative fetal outcomes, according to findings from 2 new studies. Medscape Medical News
Category:   Articles > Family Medicine


4. CD133 Not a Specific Marker of Colon Cancer Stem Cells
  Contrary to the recently proposed designation of the protein CD133 as a marker of colon cancer stem cells, CD133 is widely expressed by most cells, and both CD133+ and CD133– cells were able to generate tumors when transplanted into immunocompromised mice. Medscape Medical News
Category:   Articles > Family Medicine


5. Telaprevir Increases Efficacy of Standard HCV Therapy
  Telaprevir added to standard treatment in previously untreated patients with chronic hepatitis C virus infection resulted in significantly higher rates of sustained virologic response than standard treatment alone, as reported in related trials from the United States and Europe. Medscape Medical News
Category:   Articles > Family Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS